NAFDAC NIGERIA (@NafdacAgency) / X

NAFDAC NIGERIA

5,195 posts

NAFDAC NIGERIA

@NafdacAgency

Official account of the National Agency for Food and Drug Administration and Control, Nigeria. Follow for updates on the Agency's activities.

Abuja Nigeria

Joined April 2011

Pinned
NAFDAC NIGERIA
@NafdacAgency
Mar 31
With the launch of the NAFDAC Call Centre, you can report issues, make enquiries, or get verified information on regulated products and services. 📞 Complaints: 0800-1-NAFDAC (0800-1-623322) 📞 Enquiries: 0700-1-NAFDAC (0700-1-623322) Call. Speak. Resolve. Your voice helps us
11K
NAFDAC NIGERIA
@NafdacAgency
22h
Replying to @NafdacAgency
Although the recall action was initiated in Brazil by the Brazilian regulatory authority, NAFDAC is monitoring the situation and will take appropriate regulatory actions should any of the affected products be identified in the Nigerian supply chain. Consumers in possession of
174
NAFDAC NIGERIA
@NafdacAgency
22h
Replying to @NafdacAgency
Products Details •Product Name: Impala nail polish •Product Manufacturer: Laboratório Avamiller de Cosméticos Ltda. Affected Batches The recall applies to all batches of the following products: •Plus, Gel Esmalte Impala Gel •Esmalte Gel Impala Gel Plus •Gel Plus Impala
309
NAFDAC NIGERIA
@NafdacAgency
22h
Replying to @NafdacAgency
NAFDAC received a notification that the Brazilian Health Regulatory Agency, the Agência Nacional de Vigilância Sanitária (ANVISA), announced a recall of specific Impala brand gel nail polish products manufactured by Laboratório Avamiller de Cosméticos Ltd. The recall was
544
NAFDAC NIGERIA
@NafdacAgency
22h
Public Alert No. 029/2026. Recall of Impala Brand Gel Nail Polish Products by Brazilian Health Regulatory Authority(ANVISA) #NAFDACAlerts bit.ly/4owTqRG
815
NAFDAC NIGERIA
@NafdacAgency
23h
Replying to @NafdacAgency
Although the affected product was distributed and recalled within the United States, NAFDAC remains committed to safeguarding public health and will continue surveillance activities to ensure the quality, safety, and efficacy of medicines circulating in Nigeria, and prevent the
308
NAFDAC NIGERIA
@NafdacAgency
23h
Replying to @NafdacAgency
Product Details •Product Name: Children’s Ibuprofen Oral Suspension, USP •Strength: 100mg/5mL •Dosage Form: Oral Suspension •Pack Size: 4 fl. oz. (120 mL) bottles •Product Manufacturer: Strides Pharma Inc., India (manufactured the product for Taro Pharmaceuticals U.S.A.,
424
NAFDAC NIGERIA
@NafdacAgency
23h
Replying to @NafdacAgency
NAFDAC received a notification that the United States Food and Drug Administration (USFDA) has announced the recall of approximately 90,000 bottles of Children’s Ibuprofen Oral Suspension, USP (100 mg/5 mL) due to the presence of foreign material in the product. Strides Pharma
928
NAFDAC NIGERIA
@NafdacAgency
23h
Public Alert No. 028/2026. Recall of children’s Ibuprofen Oral Suspension in the United States due to potential contamination with foreign material #NAFDACAlerts bit.ly/4e5NdZg
1.5K
NAFDAC NIGERIA
@NafdacAgency
Jun 12
🇳🇬 Today, NAFDAC joins Nigerians in celebrating Democracy Day, a testament to our nation’s enduring commitment to freedom, democratic governance, and national development. As we celebrate this milestone, we reaffirm our commitment to protecting public health through effective
297
NAFDAC NIGERIA
@NafdacAgency
Jun 5
Breastfeeding can sometimes feel overwhelming, but no mother should have to do it alone. The support of family, friends, healthcare workers, workplaces, and communities can make breastfeeding easier and more successful. As we prepare for #WorldBreastfeedingWeek, let us remember
662
NAFDAC NIGERIA
@NafdacAgency
Jun 4
Replying to @NafdacAgency
Healthcare professionals and consumers are advised to report any suspicion of the sale of substandard and falsified medicines or medical devices to the nearest NAFDAC office, call 0800-162-3322, or send an email to [email protected]
377
NAFDAC NIGERIA
@NafdacAgency
Jun 4
Replying to @NafdacAgency
Product Details Omnipaque 350mg/ml and 300mg/ml injections are registered for use in Nigeria, NRN: B4-0328 and B4-0329, respectively, while Visipaque is not registered. Stated Manufacturer: GE Healthcare Ireland Limited. See the list of affected products and batches >>
483